0001708138-20-000032.txt : 20200408
0001708138-20-000032.hdr.sgml : 20200408
20200408160249
ACCESSION NUMBER: 0001708138-20-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200406
FILED AS OF DATE: 20200408
DATE AS OF CHANGE: 20200408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20782049
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-04-06
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
Common Stock
2020-04-06
4
M
0
3000
272.7
A
27373
D
Common Stock
2020-04-06
4
F
0
2304
499.95
D
25069
D
Common Stock
2020-04-07
4
S
0
694
497.5
D
24375
D
Common Stock
2020-04-07
4
S
0
2
502.81
D
24373
D
Common Stock
172
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
272.7
2020-04-06
4
M
0
3000
0.0
D
2023-09-09
Common Stock
3000
42500
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2020-04-07